Home › Type 1 Diabetes › Virginia
Type 1 Diabetes clinical trials in Virginia
10 studies for Type 1 Diabetes are looking for participants at sites in Virginia.
Cities in Virginia
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- University of Virginia, Charlottesville
RecruitingPhase 3
Ages 1 to 35 · All sexes · Updated Sep 22, 2026 · NCT07222332A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- University of Virginia, Charlottesville
RecruitingPhase 3
Ages 1 to 35 · All sexes · Updated Sep 22, 2026 · NCT07222137A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Uva Children's Battle Building- Site Number : 8400060, Charlottesville
RecruitingPhase 3
Ages 1 to 25 · All sexes · Updated Sep 14, 2026 · NCT07088068A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- VCU Medical Center, Richmond, Richmond
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- University of Virginia Health System - Pediatric Diabetes Clinic, Charlottesville
RecruitingPhase 2
Ages 5 to 40 · All sexes · Updated Aug 24, 2026 · NCT07187531INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- University of Virginia, Charlottesville
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Aug 13, 2026 · NCT07224321Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction
- University of Virginia Center for Diabetes Technology, Charlottesville
Recruiting
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT07507708Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes
- University of Virginia, Charlottesville
RecruitingHealthy volunteers welcome
Ages 21 to 50 · All sexes · Updated May 7, 2026 · NCT07573228Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
- University of Virginia Health System, Charlottesville
Recruiting
Ages 18 to 40 · All sexes · Updated Feb 25, 2026 · NCT05653518Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes
- University of Virginia, Charlottesville
RecruitingPhase 2
Ages 18 to 45 · All sexes · Updated Feb 25, 2026 · NCT07186660From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.